A randomised controlled trial on roles of prostaglandin E1 nebulization among patients undergoing one lung ventilation

BACKGROUND: Prostaglandin E1 (PGE1) has been reported to maintain adequate oxygenation among patients under 60% FiO(2) one-lung ventilation (OLV). This research aimed to explore whether PGE1 is safe in pulmonary shunt and oxygenation under 40% FiO(2) OLV and provide a reference concentration of PGE1...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Pengyi, Gu, Lianbing, Tan, Jing, Song, Zhenghuan, Bian, Qingming, Jiao, Dian, Xu, Zeping, Wang, Lijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759228/
https://www.ncbi.nlm.nih.gov/pubmed/35027012
http://dx.doi.org/10.1186/s12890-022-01831-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759228/
https://www.ncbi.nlm.nih.gov/pubmed/35027012
http://dx.doi.org/10.1186/s12890-022-01831-4

Ejemplares similares